Anavex Life Sciences Corp (AVXL)

[Gator328]

The plan is unfolding nicely.

Step 1: Seek Rett Approval

Step 2: Get Rare Disease Priority Review voucher from FDA

Step 3: Use Priority Review voucher to expedite the A273 Alzheimer's or PDD approval process

Step 4: Profit

Step 5: Use those profits to advance A371 and other pipeline candidates

In my opinion, it all hinges on A273 being approved for Rett syndrome. Let the other companies cannibalize themselves over being first to market with Alzheimer's -- they may even submit their NDA before Anavex, but Anavex will be able to leapfrog them once it's in the FDA's hands thanks to its initial focus on Rett and securing the priority review voucher.